Study S000987

Albuminuria Reduction Trial and Investigation With Survodutide Treatment in CKD

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07206290
Acronym: ARTIST-CKD
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: NOT_YET_RECRUITING
Enrollment: 120
Start: 2026-03-02
Primary completion: 2027-11-30
Lead sponsor: University Medical Center Groningen
Conditions: Chronic Kidney Disease
Interventions: DRUG:Survodutide (BI 456906); DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: CTIS:2025-523184-37-00; NIH:2025

Registered primary outcomes

Change in first morning void UACR [From baseline to week 32/36]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.